CAIRE DIAGNOSTICS INC — FDA Facility Profile

FEI 3013216353

CAIRE DIAGNOSTICS INC is an FDA-inspected facility (FEI 3013216353) located in Pleasanton, CA, US. RegDataLab tracks 1 FDA inspection at this facility.

Reviewing CAIRE DIAGNOSTICS INC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check CAIRE DIAGNOSTICS INC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Aug 3, 2021: Voluntary Action Indicated (VAI)
Inspections on record
1 (1 VAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
1, latest Feb 26, 2021

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Aug 3, 2021Voluntary Action Indicated (VAI)DHR - not or inadequately maintained (21 CFR 820.184)
Lack of or inadequate procedures (21 CFR 820.100(a))
Investigation of device failures (21 CFR 820.198(c))
Identification procedures, Lack of or inadequate procedures (21 CFR 820.60)

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Feb 26, 2021Not yet classifiedZ-1284-2021CAIRE DIAGNOSTICS FenomPro REF 900-0001 SN ***** - Product Usage: a portable, non-invasive…
Erroneously high FeNO levels which may contribute to premature discontinuation of effective asthma treatment and persistent underlying…

Facility details

Company
CAIRE DIAGNOSTICS INC
Location
Pleasanton, CA (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.